Developing new treatments for infectious diseases
Official title: Task D17: Non-Clinical Services for Development of Interventional Agents for Infectious Diseases
Funded at Sri International · NIH-11202387 · Data updated 2026-11-12
This study is working on developing new medicines to help fight infections caused by germs and toxins, with the goal of finding better treatments for patients who need them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sri International NIH-funded |
| Lab location | 1 site (Menlo Park, United States) |
| Project start | August 30, 2024 |
| Project end | August 29, 2025 |
| Funding year | 2024 |
| Award (this year) | $260,145 |
| NIH project number | 272201800001I-0-759302400004-1 |
| Project ID | NIH-11202387 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals affected by infectious diseases or those at high risk of infection.
✕Less likely to help
Patients with non-infectious diseases or conditions unrelated to infectious pathogens may not benefit from this research.
What this research studies
This research focuses on creating and evaluating new therapeutic agents aimed at combating infectious diseases caused by various pathogens and toxins. It involves a series of preclinical services, including planning and assessing product development, identifying promising drug candidates, and conducting safety and efficacy tests both in laboratory settings and in living organisms. Patients can benefit from this research as it aims to bring new treatments to market that could effectively address serious infections.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective treatments for infectious diseases.
How similar studies have gone: Other research in the field of developing therapeutic agents for infectious diseases has shown promise, indicating that this approach is both relevant and potentially impactful.
Where this research is happening
-
Sri International
Menlo Park, United States Active
Researchers
- Principal investigator: Mirasilas, Jon — Sri International
- Study coordinator: Mirasilas, Jon
Related research
Other NIH-funded projects on the same topics.
-
ABCD-USA Consortium: A large, long-term study tracking brain development in youth
A large, long-term study at multiple sites is following thousands of children and teens to understand how their brains grow and relate to health, behavior, and environment.
-
BioCyc, MetaCyc, and EcoCyc knowledge bases expansion with AI assistance
Aims to speed up and improve the BioCyc family of knowledge bases that map genomes and metabolic pathways, using AI to accelerate data curation for researchers who study microbes and metabolism.
-
Tracking HIV, alcohol use, and brain aging with MRI
Aging people living with HIV who also have alcohol use disorder are being studied to understand how brain changes relate to balance, movement, and thinking over time using MRI.
-
NCANDA-SRI: Studying how adolescent drinking affects brain development and adulthood
A long-term study at SRI International follows teens who started drinking to see how it may change brain development and risk for alcohol use disorders as they grow into adults.
-
Brain changes behind thinking and movement problems in older people with HIV and Parkinson's
This project looks at brain changes that may explain why older people living with HIV sometimes have thinking and movement problems similar to Parkinson's.
-
ABCD brain and child development project at SRI
Following children who were 9–10 years old to learn how their brains, health, and behavior change from childhood into young adulthood.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.